팝업레이어 알림
-
|Hwi Jin Ko (CEO)
Education & Carrer
- Ph.D., Biolochemical Engineering, Seoul National University, Republic of Korea
- Research Professor, Seoul National University
- Vice President (CTO), Amicogen Pharma Inc.
- Co-director, Analytical Core, National Mouse Phenotyping Center at University of Massachusetts
- Instructor, Program in Molecular Medicine, University of Massachusetts Medical School University, USA
- Postdoctoral Scholar, Pennsylvania State University College of Medicine, USA
- Researcher, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Republic of Korea
-
|Myung Jin Kim (CSO)
Education & Carrer
- Ph.D., Chemical Engineering, Clarkdon University, USA
- Vice President, The Korean Society for Biotechnology and Bioengineering (KSBB)
- Head of Life Sciences R&D, LG Chem (Executive Vice President)
-
|Tai Hyun Park (CTO)
Education & Carrer
- Ph.D., Chemical Engineering, Purdue University, USA
- Professor, School of Chemical and Biological Engineering, Seoul National University
- Vice President, Korean Academy of Science and Technology (KAST)
- Director, BK21 FOUR Program in Chemical Engineering
- Member of Board of Directors, Korea Support Committee for International Vaccine Institute (IVI)
- President, The Korea Foundation for the Advancedment of Science & Creativity (KOFAC)
- President, Advanced Institutes of Convergence Technology (AICT)
- President, The Korean Society for Biotechnology and Bioengineering (KSBB)